Video Experimental Relacionado
Updated: May 9, 2026
15:53
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
CIP2A inhibe el PP2A en las neoplasias malignas humanas.
Melissa R Junttila1, Pietri Puustinen, Minna Niemelä
1Centre for Biotechnology, University of Turku and Abo Akademi University, 20520 Turku, Finland.
Cell
|July 17, 2007
Resumen
El inhibidor canceroso de PP2A (CIP2A) es una oncoproteína recientemente identificada que inhibe la actividad de la proteína fosfatasa 2A (PP2A). CIP2A estabiliza el factor de transcripción oncogénico c-Myc, promoviendo el desarrollo del cáncer humano.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- La bioquímica es la bioquímica.
Sus antecedentes:
- La inhibición de la proteína fosfatasa 2A (PP2A) es crucial para la transformación de las células humanas.
- Los mecanismos moleculares de la inhibición de PP2A en los cánceres humanos siguen siendo en gran medida desconocidos.
Objetivo del estudio:
- Identificar y caracterizar un inhibidor celular de PP2A con actividad oncogénica.
- Para aclarar el papel de este inhibidor en las malignidades humanas.
Principales métodos:
- Estudios de interacción con las proteínas para identificar CIP2A.
- Los ensayos de actividad enzimática miden la inhibición de PP2A.
- Análisis celulares para la transformación y la formación de tumores.
- Análisis de la expresión de CIP2A en cánceres humanos.
Principales resultados:
- Se identificó una nueva proteína, el inhibidor canceroso de PP2A (CIP2A), como un inhibidor de PP2A.
- CIP2A interactúa directamente con c-Myc, inhibiendo la actividad de PP2A en la serina 62 (S62).
- CIP2A previene la degradación de c-Myc, promueve el crecimiento independiente del anclaje e induce la formación de tumores.
- CIP2A se sobreexpresa en el carcinoma de células escamosas de la cabeza y el cuello (HNSCC) y el cáncer de colon.
Conclusiones:
- CIP2A es una oncoproteína humana que inhibe PP2A y estabiliza c-Myc.
- CIP2A juega un papel importante en el desarrollo de tumores malignos en humanos.
Videos de Conceptos Relacionados
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...